Clinical trial NCT02921321 - References

Musculoskeletal Diseases — Pilot Study of Cardiac MR in Patients With Muscular Dystrophy

Citation(s)

•   Anderson KP, Walker R, Urie P, Ershler PR, Lux RL, Karwandee SV
  Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1993 Jul;92(1):122-40. doi: 10.1172/JCI116540.
•   Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P
  The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol. 1995 Jan;27(1):291-305. doi: 10.1016/s0022-2828(08)80028-4.
•   Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR
  The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008 Dec 16;52(25):2148-55. doi: 10.1016/j.jacc.2008.09.014.
•   Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS
  Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens. 1995 Mar;8(3):221-8. doi: 10.1016/0895-7061(94)00178-E.
•   Caiani EG, Corsi C, Sugeng L, MacEneaney P, Weinert L, Mor-Avi V, Lang RM
  Improved quantification of left ventricular mass based on endocardial and epicardial surface detection with real time three dimensional echocardiography. Heart. 2006 Feb;92(2):213-9. doi: 10.1136/hrt.2005.060889. Epub 2005 May 12.
•   Cao Y, Huang DQ, Shih G, Prince MR
  Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol. AJR Am J Roentgenol. 2016 Feb;206(2):414-9. doi: 10.2214/AJR.15.15327. Epub 2015 Dec 23.
•   Castillo E, Osman NF, Rosen BD, El-Shehaby I, Pan L, Jerosch-Herold M, Lai S, Bluemke DA, Lima JA
  Quantitative assessment of regional myocardial function with MR-tagging in a multi-center study: interobserver and intraobserver agreement of fast strain analysis with Harmonic Phase (HARP) MRI. J Cardiovasc Magn Reson. 2005;7(5):783-91. doi: 10.1080/10976640500295417.
•   Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M
  Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol. 2002 Apr 1;89(7):838-41. doi: 10.1016/s0002-9149(02)02195-1.
•   Cox GF, Kunkel LM
  Dystrophies and heart disease. Curr Opin Cardiol. 1997 May;12(3):329-43.
•   de Bakker JM, van Capelle FJ, Janse MJ, Tasseron S, Vermeulen JT, de Jonge N, Lahpor JR
  Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. J Am Coll Cardiol. 1996 Apr;27(5):1071-8. doi: 10.1016/0735-1097(95)00612-5.
•   de Lemos JA, McGuire DK, Khera A, Das SR, Murphy SA, Omland T, Drazner MH
  Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study. Am Heart J. 2009 Apr;157(4):746-53.e2. doi: 10.1016/j.ahj.2008.12.017. Epub 2009 Feb 20.
•   de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH
  Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation. 1996 Jan 15;93(2):259-65. doi: 10.1161/01.cir.93.2.259.
•   Deburgrave N, Daoud F, Llense S, Barbot JC, Recan D, Peccate C, Burghes AH, Beroud C, Garcia L, Kaplan JC, Chelly J, Leturcq F
  Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat. 2007 Feb;28(2):183-95. doi: 10.1002/humu.20422.
•   Devereux RB, Dahlof B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K
  Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation. 2004 Sep 14;110(11):1456-62. doi: 10.1161/01.CIR.0000141573.44737.5A. Epub 2004 Aug 23.
•   Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH
  Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984 Dec;4(6):1222-30. doi: 10.1016/s0735-1097(84)80141-2.
•   Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B
  Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004 Nov 17;292(19):2350-6. doi: 10.1001/jama.292.19.2350.
•   Fernandes VR, Polak JF, Cheng S, Rosen BD, Carvalho B, Nasir K, McClelland R, Hundley G, Pearson G, O'Leary DH, Bluemke DA, Lima JA
  Arterial stiffness is associated with regional ventricular systolic and diastolic dysfunction: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):194-201. doi: 10.1161/ATVBAHA.107.156950. Epub 2007 Oct 25.
•   Flacke SJ, Fischer SE, Lorenz CH
  Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology. 2001 Mar;218(3):703-10. doi: 10.1148/radiology.218.3.r01fe18703.
•   Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS, Wong ND, Smith VE, Gottdiener J
  M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 2001 May 1;87(9):1051-7. doi: 10.1016/s0002-9149(01)01460-6.
•   Haider AW, Larson MG, Benjamin EJ, Levy D
  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol. 1998 Nov;32(5):1454-9. doi: 10.1016/s0735-1097(98)00407-0.
•   Harris PA, Lorenz CH, Holburn GE, Overholser KA
  Regional measurement of the Gd-DTPA tissue partition coefficient in canine myocardium. Magn Reson Med. 1997 Oct;38(4):541-5. doi: 10.1002/mrm.1910380406.
•   Hees PS, Fleg JL, Lakatta EG, Shapiro EP
  Left ventricular remodeling with age in normal men versus women: novel insights using three-dimensional magnetic resonance imaging. Am J Cardiol. 2002 Dec 1;90(11):1231-6. doi: 10.1016/s0002-9149(02)02840-0.
•   Hoffman EP, Brown RH Jr, Kunkel LM
  Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919-28. doi: 10.1016/0092-8674(87)90579-4.
•   Hollingsworth KG, Garrood P, Eagle M, Bushby K, Straub V
  Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve. 2013 Oct;48(4):586-8. doi: 10.1002/mus.23879. Epub 2013 Aug 30.
•   Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE
  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008 Sep;295(3):H1234-H1242. doi: 10.1152/ajpheart.00429.2008. Epub 2008 Jul 25.
•   Jost G, Lenhard DC, Sieber MA, Lohrke J, Frenzel T, Pietsch H
  Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents. Invest Radiol. 2016 Feb;51(2):83-9. doi: 10.1097/RLI.0000000000000242.
•   Kannel WB, Gordon T, Castelli WP, Margolis JR
  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med. 1970 Jun;72(6):813-22. doi: 10.7326/0003-4819-72-6-813. No abstract available.
•   Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RN, Kirkels H, Janse MJ, de Bakker JM
  Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation. 2001 Dec 18;104(25):3069-75. doi: 10.1161/hc5001.100833.
•   Kjeldsen SE, Dahlof B, Devereux RB, Julius S, Aurup P, Edelman J, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H; LIFE (Losartan Intervention for Endpoint Reduction) Study Group
  Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA. 2002 Sep 25;288(12):1491-8. doi: 10.1001/jama.288.12.1491.
•   Lavie CJ, Milani RV, Ventura HO, Messerli FH
  Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol. 2006 Nov 15;98(10):1396-9. doi: 10.1016/j.amjcard.2006.06.037. Epub 2006 Oct 2.
•   Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP
  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med. 1989 Jan 15;110(2):101-7. doi: 10.7326/0003-4819-110-2-101.
•   Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP
  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990 May 31;322(22):1561-6. doi: 10.1056/NEJM199005313222203.
•   Lim LE, Campbell KP
  The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol. 1998 Oct;11(5):443-52. doi: 10.1097/00019052-199810000-00006.
•   Mathews KD, Moore SA
  Limb-girdle muscular dystrophy. Curr Neurol Neurosci Rep. 2003 Jan;3(1):78-85. doi: 10.1007/s11910-003-0042-9.
•   McLenachan JM, Dargie HJ
  Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens. 1990 Oct;3(10):735-40. doi: 10.1093/ajh/3.10.735.
•   Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, et al
  Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med. 1989 Jun 15;320(24):1592-7. doi: 10.1056/NEJM198906153202405.
•   Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Lochmuller H, Ginjaar HB, Aartsma-Rus AM, van Ommen GJ, den Dunnen JT, 't Hoen PA
  Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord. 2011 Aug;21(8):569-78. doi: 10.1016/j.nmd.2011.05.011. Epub 2011 Jul 2.
•   Niendorf HP, Haustein J, Cornelius I, Alhassan A, Clauss W
  Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med. 1991 Dec;22(2):222-8; discussion 229-32. doi: 10.1002/mrm.1910220212.
•   Nigro G, Comi LI, Politano L, Bain RJ
  The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol. 1990 Mar;26(3):271-7. doi: 10.1016/0167-5273(90)90082-g.
•   Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlof B; LIFE Study Investigators
  Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004 Nov 17;292(19):2343-9. doi: 10.1001/jama.292.19.2343.
•   Osman NF, Prince JL
  Visualizing myocardial function using HARP MRI. Phys Med Biol. 2000 Jun;45(6):1665-82. doi: 10.1088/0031-9155/45/6/318.
•   Pack NA, Dibella EV, Wilson BD, McGann CJ
  Quantitative myocardial distribution volume from dynamic contrast-enhanced MRI. Magn Reson Imaging. 2008 May;26(4):532-42. doi: 10.1016/j.mri.2007.10.003. Epub 2008 Feb 20.
•   Rosen BD, Saad MF, Shea S, Nasir K, Edvardsen T, Burke G, Jerosch-Herold M, Arnett DK, Lai S, Bluemke DA, Lima JA
  Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol. 2006 Mar 21;47(6):1150-8. doi: 10.1016/j.jacc.2005.08.078. Epub 2006 Feb 23.
•   Rossi MA
  Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens. 1998 Jul;16(7):1031-41. doi: 10.1097/00004872-199816070-00018.
•   Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlof B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators
  Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy. Circulation. 2009 Feb 3;119(4):530-7. doi: 10.1161/CIRCULATIONAHA.108.826214. Epub 2009 Jan 19.
•   Turakhia MP, Schiller NB, Whooley MA
  Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol. 2008 Nov 1;102(9):1131-5. doi: 10.1016/j.amjcard.2008.06.036. Epub 2008 Aug 27.
•   van Hoeven KH, Factor SM
  A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation. 1990 Sep;82(3):848-55. doi: 10.1161/01.cir.82.3.848.
•   Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, Solinas P, Gorini M, Maggioni AP; MAVI (MAssa Ventricolare sinistra nell'Ipertensione) Study Group
  Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol. 2001 Dec;38(7):1829-35. doi: 10.1016/s0735-1097(01)01663-1.
•   Viollet L, Gailey S, Thornton DJ, Friedman NR, Flanigan KM, Mahan JD, Mendell JR
  Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy. Muscle Nerve. 2009 Sep;40(3):438-42. doi: 10.1002/mus.21420.
•   Weber KT, Brilla CG
  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991 Jun;83(6):1849-65. doi: 10.1161/01.cir.83.6.1849.
•   Wu YL, Ye Q, Sato K, Foley LM, Hitchens TK, Ho C
  Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009 Jun;2(6):731-41. doi: 10.1016/j.jcmg.2009.01.013.

Pilot Study of Cardiac Magnetic Resonance in Patients With Muscular Dystrophy

Details for clinical trial NCT02921321